We just received data on a new analyst forecast for $NTRA. Mark Massaro from BTIG set a price target of 260.0 for NTRA.
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
Should you buy $NTRA?
Some analysts are better than others. To view the past performance of BTIG, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 11 analysts offer price targets for $NTRA in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $260.0 on 12/05/2025
- Tejas Savant from Morgan Stanley set a target price of $265.0 on 12/02/2025
- Casey Woodring from JP Morgan set a target price of $250.0 on 11/25/2025
- Elizabeth Garcia from UBS set a target price of $280.0 on 11/18/2025
- Mason Carrico from Stephens & Co. set a target price of $235.0 on 11/13/2025
- David Westenberg from Piper Sandler set a target price of $230.0 on 11/11/2025
- Kyle Mikson from Canaccord Genuity set a target price of $250.0 on 11/07/2025
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 201 times in the past 6 months. Of those trades, 0 have been purchases and 201 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 25 sales selling 219,856 shares for an estimated $41,950,665.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 12 sales selling 111,718 shares for an estimated $20,850,493.
- ROELOF BOTHA has made 0 purchases and 11 sales selling 75,000 shares for an estimated $17,708,935.
- JONATHAN SHEENA has made 0 purchases and 71 sales selling 60,564 shares for an estimated $11,290,945.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 9 sales selling 26,187 shares for an estimated $4,428,423.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 27 sales selling 23,870 shares for an estimated $4,152,157.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 23 sales selling 18,162 shares for an estimated $2,985,740.
- ROY D. BAYNES has made 0 purchases and 8 sales selling 12,780 shares for an estimated $2,809,688.
- GAIL BOXER MARCUS has made 0 purchases and 7 sales selling 10,917 shares for an estimated $1,733,888.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 7 sales selling 4,775 shares for an estimated $783,289.
- ROWAN E CHAPMAN sold 2,750 shares for an estimated $459,222
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Revenue
$NTRA had revenues of $592.2M in Q3 2025. This is an increase of 34.66% from the same period in the prior year.
You can track NTRA financials on Quiver Quantitative's NTRA stock page.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/22, 08/22 and 1 sale worth up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Hedge Fund Activity
We have seen 384 institutional investors add shares of $NTRA stock to their portfolio, and 327 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KYNAM CAPITAL MANAGEMENT, LP removed 1,167,570 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $197,249,275
- JPMORGAN CHASE & CO added 1,003,129 shares (+9.4%) to their portfolio in Q3 2025, for an estimated $161,473,675
- POINTSTATE CAPITAL LP added 985,963 shares (+702.0%) to their portfolio in Q3 2025, for an estimated $158,710,464
- FRANKLIN RESOURCES INC added 727,366 shares (+37.5%) to their portfolio in Q3 2025, for an estimated $117,084,105
- AQR CAPITAL MANAGEMENT LLC added 673,315 shares (+39.0%) to their portfolio in Q3 2025, for an estimated $108,383,515
- INVESCO LTD. removed 649,956 shares (-34.7%) from their portfolio in Q3 2025, for an estimated $104,623,417
- AMERIPRISE FINANCIAL INC removed 626,686 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $100,877,645
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
